close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar78Point07
Implied share price

Buy Undervalued by 24.8%

5% margin of safety What's this?

EV / EBITDA
Use Average
ABT
Abbott Laboratories
JNJ
Johnson & Johnson
Change
PFE
Pfizer Inc.
Change
NVS
Novartis AG (ADR)
Change
SGP
Schering-Plough Corporation
Change
10.92 8.87 8.11 6.22 8.01 25.26
All amounts in millions
from last financial year
         
Implied Share Price $78.07 $84.03 $40.92 $73.22 $10.61
Market Cap 98,415 174,696 169,531 140,920 118,198
Net Debt 7,317 -12,634 12,140 15,154 4,798
Enterprise Value (EV) 105,732 162,062 181,671 141,355 51,349
Revenue 38,851 65,030 67,425 59,375 18,502
EBITDA 11,924 19,985 29,186 17,637 2,033
Percent 30.7 % 30.7 % 43.3 % 29.7 % 11.0 %
EBIT 8,880 16,833 20,160 12,881 860
Percent 22.9 % 25.9 % 29.9 % 21.7 % 4.6 %
Balance Sheet          
Total Assets 60,276 113,644 188,002 117,496 28,117
Total Liabilities 35,837 56,564 105,812 51,652 17,588
Shareholders Equity 24,439 57,080 82,190 65,844 10,529.0

Price history

Comments

No comments yet. Login to comment.